Synaps

Developing novel photodynamic therapies for neurosurgery

Synaps
  • About
    • Overview
    • Partnership >
      • Onco-THAI Inserm U1189
      • University of Lille
      • Lille University Hospital
      • Inserm
      • ECRIN
      • Leitat Technological Center
      • IDDI
      • Medical University of Graz
      • OP2
      • Erasme Hospital
  • Research
    • Overview
    • Clinical trial
    • Publications
  • Medical information
    • Overview
    • Glioblastoma
    • PhotoDynamic Therapies
  • News
  • Contact

  • About
    • Overview
    • Partnership >
      • Onco-THAI Inserm U1189
      • University of Lille
      • Lille University Hospital
      • Inserm
      • ECRIN
      • Leitat Technological Center
      • IDDI
      • Medical University of Graz
      • OP2
      • Erasme Hospital
  • Research
    • Overview
    • Clinical trial
    • Publications
  • Medical information
    • Overview
    • Glioblastoma
    • PhotoDynamic Therapies
  • News
  • Contact

Medical information

Picture
Copyright CHRU Lille

Photodynamic Therapies (PDT) to treat glioblastoma (GBM)

Synaps aims to enhance photodynamic therapies applied to the treatment of glioblastoma, a very agressive brain cancer type, still incurable today.
With a rising incidence up to 5 new cases each year per 100 000 people, glioblastoma is a main cause of death by cancer among the young adults population.
Glioblastoma is still an incurable and a very agressive brain cancer, whose median survival is less than 18 months.
More about glioblastoma

Photodynamic therapy (PDT) to complete neurosurgery

Surgery is the first standard treatment for glioblastoma, that aims to achieve a maximum reduction of tumour volume without affecting the functional outcome of patients.

But even when surgical resection is complete, the invasiveness of glioblastoma and its proliferating nature do not allow a local control with standard therapeutic protocols.

Photodynamic therapy (PDT) opens new possibilities to tackle this challenge and stop tumour growth.
More about PDT
Picture
Copyright ONCO-THAI
Université Lille 2
Onco Thai
Inserm
CHRU Lille
Picture
 Legal notice - Credits